Report - ROR Agonist LYC-55716, a Novel, Small-Molecule Immunotherapy: … · 2018. 1. 29. · efficacy and levels of TILs in the tumor microenvironment.5,6 o Analysis of TCGA RNA sequencing

Please pass captcha verification before submit form